How it works
Get started by filling out the online enrollment application to find out if you are eligible for assistance.
NiceRx verifies your eligibility for medication assistance and notifies you if you are pre-qualified. The pharmaceutical company provides your medication for free, and you only pay our service fee.
We will request documents to be submitted by you and your healthcare provider that are required by the pharmaceutical company to complete your enrollment.
Once approved, the pharmaceutical company typically ships a 90-day supply of medication to your home or healthcare provider’s address. Final acceptance is determined by the pharmaceutical company.
Your monthly Vizimpro cost savings if eligible
If you are eligible for the Vizimpro patient assistance program you can receive your medication for free. Our monthly service fee of $49 per medication covers the cost of our services in applying for the program and requesting your ongoing refills on your behalf. If you obtain your Vizimpro through NiceRx, you will only pay $49 a month regardless of the retail price of your medication.
Am I eligible for the Vizimpro patient assistance program?
You could receive your Vizimpro without paying the full retail price if you meet the eligibility criteria for assistance. The eligibility requirements are set by the pharmaceutical companies that are providing assistance programs. At NiceRx, we review each application individually, although the main factors considered by most programs are:
- I am a permanent, legal resident of the United States or Puerto Rico
- I am uninsured or my insurance doesn’t cover my medication
- I meet certain income eligibility requirements
How do I apply for Vizimpro patient assistance?
We do everything that we can to take the hassle and stress out of applying for patient assistance programs. Simply start by filling in our enrollment application. We will ask for details about your healthcare provider, your insurance, and your household income. This information is required by the pharmaceutical companies you are applying to for assistance. We may also be able to help you access patient assistance for other medications that you have been prescribed, so be sure to tell us about any medications you are taking as well as Vizimpro.
NiceRx will review the information you have provided, and if we determine that you may be eligible for assistance, we will seek to enroll you in the Vizimpro patient assistance program. We will handle the enrollment process for you by working with your healthcare provider and preparing all the required paperwork for your doctor to sign. We will also request your Vizimpro medication refills on your behalf for up to 1 year once you are enrolled in the program.
Is NiceRx a Vizimpro coupon provider?
At NiceRx, we help eligible individuals access the Vizimpro patient assistance program. This means that we are not a Vizimpro coupon, a Vizimpro discount card, or a Vizimpro copay card provider. We do not offer any medication trial offers or free Vizimpro samples.
Can NiceRx help me get Vizimpro cheaper if I have insurance?
We may be able to help you if you have insurance, including if your insurance company will not pay for your Vizimpro medication, or you have a high copay or coinsurance responsibility. We may even be able to assist if you do not have insurance. Please fill in our enrollment application to find out more.
How much does Vizimpro cost without insurance?
Vizimpro costs without insurance will vary depending on how many you buy and the retailer you buy it from. As a guide, Vizimpro oral tablet 15 mg will typically cost around $15,200 for 30 tablets. If you obtain your medication through NiceRx, you will pay a flat monthly rate of $49 per medication regardless of its retail price.
How much does Vizimpro cost with insurance?
The copay of Vizimpro will vary in line with the specific terms of your healthcare plan. For further details about what you may need to pay, your insurance provider or pharmacist will be able to calculate the copay costs with your current insurance.
What is Vizimpro?
Vizimpro is an FDA (U.S. Food and Drug Administration) approved medication manufactured by Pfizer Inc. It is classed as a tyrosine kinase inhibitor indicated for the first-line treatment of patients with metastatic NSCLC (non-small cell lung cancer) with epidermal growth factor receptor (EGFR) exon 19 deletion or exon 21 L858R substitution mutations as detected by an FDA-approved test.
What doses of Vizimpro are available?
Vizimpro is available in tablet form, in the following doses: 15 mg, 30 mg, and 45 mg.
Please see the full prescribing information and always speak with a healthcare professional about any changes to your dose so they can monitor and evaluate your condition.
Vizimpro active ingredients
Vizimpro contains dacomitinib as the active ingredient.
Vizimpro side effects
The most common side effects of Vizimpro in clinical trials (incidence >20%) include:
- Decreased appetite, decreased appetite
- Dry skin
- Alopecia (hair loss)
In rare instances, Vizimpro can cause more serious side effects. These can include:
- Interstitial lung disease (ILD)
- Diarrhea – withhold and reduce the dose of Vizimpro based on the severity
- Dermatologic adverse reactions – report any worsening skin reactions right away
- Embryo-fetal toxicity – can cause fetal harm in pregnant women. Females of reproductive potential are advised to use effective contraception
Your doctor will assess the benefits of using Vizimpro against your risk of side effects. Patients are encouraged to report negative side effects or adverse events of Vizimpro to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Vizimpro drug interactions
Vizimpro can interact with other medications. These include:
- Proton pump inhibitors – use locally-acting antacids or H2-receptor antagonist
- CYP2D6 substrates – avoid concomitant use with Vizimpro where minimal increases in the concentration of the CYP2D6 substrate may lead to serious or life-threatening toxicities
This list is not exhaustive and other prescription drugs may interact with Vizimpro.
You should not use Vizimpro if you:
- Are allergic to the active ingredient dacomitinib
- Are allergic to any of the other ingredients in Vizimpro
- Are pregnant or are planning to become pregnant – You should use effective contraception during treatment and for at least 17 days after your last dose
Talk to your doctor before using Vizimpro if you:
- Are taking any of the medications that could interact with Vizimpro
- Have renal impairment
- Are breastfeeding or are planning to breastfeed
Vizimpro is the trademark brand name for dacomitinib manufactured by Pfizer Inc. A generic version of dacomitinib is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Vizimpro savings through NiceRx.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.